2017
DOI: 10.1016/j.humpath.2016.10.005
|View full text |Cite
|
Sign up to set email alerts
|

Loss of BRCA1-associated protein 1 ( BAP1 ) expression is rare in non–small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
3

Relationship

1
9

Authors

Journals

citations
Cited by 30 publications
(17 citation statements)
references
References 16 publications
1
16
0
Order By: Relevance
“…As a matter of interest, we also asked whether MTAP immunohistochemistry might be of diagnostic use in lung adenocarcinomas and high-grade serous carcinomas, tumors in which BAP1 loss is sufficiently rare (,1% of cases) that the finding of BAP1 loss is strong evidence against either diagnosis. 18,19 For comparison, 21 adenocarcinomas of the lung were stained and showed 14% MTAP loss, as were 12 high-grade ovarian serous carcinomas, which showed 8% MTAP loss. MTAP immunohistochemistry thus does not appear to be useful in either setting.…”
Section: Discussionmentioning
confidence: 99%
“…As a matter of interest, we also asked whether MTAP immunohistochemistry might be of diagnostic use in lung adenocarcinomas and high-grade serous carcinomas, tumors in which BAP1 loss is sufficiently rare (,1% of cases) that the finding of BAP1 loss is strong evidence against either diagnosis. 18,19 For comparison, 21 adenocarcinomas of the lung were stained and showed 14% MTAP loss, as were 12 high-grade ovarian serous carcinomas, which showed 8% MTAP loss. MTAP immunohistochemistry thus does not appear to be useful in either setting.…”
Section: Discussionmentioning
confidence: 99%
“…Chromosomal deletions and somatic inactivating mutations have been identified at high frequency in uveal melanoma ( Harbour et al, 2010 ), clear cell renal carcinoma ( Peña-Llopis et al, 2012 ) and cholangiocarcinoma ( Fujimoto et al, 2015 ), increasing the potential clinical impact of our discovery. Although loss of BAP1 function is seen at far lower rates in breast carcinoma (1%) ( Stephens et al, 2012 ) and non-small cell lung carcinoma (1%) ( Owen et al, 2017 ), the high incidence of these cancers translates to a large cohort of patients.…”
Section: Discussionmentioning
confidence: 99%
“…BAP1 is an important nuclear ubiquitin hydrolase involved in the cell cycle regulation, cell proliferation, cellular differentiation, repair of DNA damage, and apoptosis [ 40 ]. Ubiquitin C-terminal hydrolase was found to be involved in sex differentiation in fish [ 41 ].…”
Section: Discussionmentioning
confidence: 99%